Pediatric Vaccines Market Research Report Analysis 2018 – 2025

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development.
“Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025” provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decision–making. This report recognizes that in this rapidly–evolving and competitive environment, up–to–date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on United States pediatric vaccines market. The report also provides clear insight into current and future developments of the United States pediatric vaccines market. Furthermore, this report provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The research includes historic data from 2010 to 2017 and forecasts until 2025.
The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccines market.
The report concludes with the profiles of major players in the United States pediatric vaccines market. The key market players are evaluated on various parameters such as company overview, pediatric vaccines portfolios and latest development & trends of the pediatric vaccines market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Sanofi Pasteur
• GlaxoSmithKline(GSK)
• Merck & Co.
• Pfizer Inc
• Grifols
Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:
• Diphtheria, Tetanus & Pertussis (DTap)
• Hepatitis A
• Varicella/Chicken Pox
• Pneumococcal
• Haemophilus Influenzae Type B (HIB)
• Polio
• Rotavirus
• Hepatitis B
• Influenza Pediatric
• Measles, Mumps & Rubella (MMR)
The Latest Industry Data Included in this Report:
• United States Pediatric Vaccines Market Size & Analysis ,2010 – 2025
• United States Pediatric Vaccines Market Share and Y–o–Y Growth (%),2010 – 2025
• United States Pediatric Vaccines Market by Disease Indication ,2010 – 2025
• 10 Pediatric Vaccines Doses Administered (Volume),2010 – 2025
• Number of Children Being Vaccinated (Volume)2010 – 2025
• 10 Pediatric Vaccines Market Size and Forecast(Value),2010 – 2025
• Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
   Product Portfolios and Latest Recent Development and Trends
The Following Key Questions have been Addressed in the Report:
• What is the size of the United States pediatric vaccines market during 2010 -2025?
• How will each segment of the United States pediatric vaccines market grow
   during the forecast period and what will be the revenue generated
   by each of the segments by the end of 2025?
• Which major pediatric vaccines provides highest market share?
• How much number of children being vaccinated during 2010 – 2025?
• How are the overall market and segments types growing?
• What are the major market drivers and inhibitors in the United States pediatric vaccines market?
• Who are the key players in the United States pediatric vaccines market and
   what are their contributions?

Thailand Outbound Tourism Market Research Report Analysis 2018 – 2025

Thailand outbound tourism market is anticipated to grow over US$ 15 Billion by 2025 with an impressive growth rate in the forecast period 2018 – 2025.
“Thailand Outbound Tourism Market Research Report 2018” provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decision–making. This report recognizes that in this rapidly–evolving and competitive environment, up–to–date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on Thailand international travelers visitation, spending, purpose of visits, main destination markets. The report also provides clear insight into current and future tourism developments of the Thailand outbound tourism market. Furthermore, this report uses country focused analysis to explore Thailand outbound tourism market. The research includes historic data from 2013 to 2017 and forecasts until 2025.
A detailed country–wise analysis of the market is provided, covering a total of 15 nations. The research study limelight growth drivers and investigates market inhibitors of Thailand outbound tourism market.
The countries included in this report are: 
United Kingdom, Taiwan, Vietnam, Korea, Hong Kong, Singapore, China, Japan, Laos, Malaysia, Australia, India, Cambodia, Myanmar and Germany
Key Findings:
• Thailand is emerging as the fastest growing outbound tourism market
• In 2017, there were more than 9 Million outbound tourist departures from Thailand
• Thai travelers likely to become major spenders in Japan
• Malaysia, Laos and Japan continue to be the top destination for Thai travelers
The Latest Industry Data Included in this Report:
 
• Thailand Outbound Tourism Market (2013 – 2025)
• Thailand Outbound Travelers Visitation & Forecast (2013 – 2025)
• Thailand Outbound Travelers Spending & Forecast (2013 – 2025)
• Thailand Outbound Travelers Visitation Share & Forecast (2013 – 2025)
• Thailand Outbound Travelers Spending Share & Forecast (2013 – 2025)
• 15 Countries Thai Travelers Visitation & Forecast (2013 – 2025)
• 15 Countries Thai Travelers Purpose of Visit & Forecast (2013 – 2025)
• 15 Countries Thai Travelers Spending & Forecast (2013 – 2025)
• Identification of Key Drivers and Inhibitors of the Thailand Outbound Tourism Market

hina In Vitro Diagnostics (IVD) Market Research Report Analysis 2018 – 2025

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.
The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.
“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.
The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025. A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue.
The report also includes assessment of in vitro diagnostics regulation in China. Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers, restraints, trends and opportunities of the China in vitro diagnostics market.
Market Segmentation by Application and Analysis (2012 – 2025)
•Clinical Chemistry
• Immunoassay
•Molecular Testing
• Self–Monitoring of Blood Glucose (SMBG)
•Point of Care Testing (POCT)
•Hematology
•Coagulation
•Microbiology
• Genetic Testing
• Infectious Diagnostics
• Histology and Cytology
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Sysmex Corporation
• Mindray Medical International Limited
• Beckman Coulter Inc
• Shanghai Fosun Pharmaceutical Group
• Thermo Fisher Scientific Inc
• Hologic Inc
• Qiagen
• Cepheid
• Bio-Rad Laboratories Inc
• Da An Gene Co. Ltd
• Shanghai Kehua Bio–Engineering Co. Ltd.
The Latest Industry Data Included in this Report:
• China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
• China In Vitro Diagnostics Market Dynamics
• China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
• China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
• China In Vitro Diagnostics Market, Company Share by Revenue, 2017
• China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
• Assessment of In Vitro Diagnostics Regulation in China
• Major Partnership Deals in China In Vitro Diagnostics Market
• Recent Developments in China In Vitro Diagnostics Market
• Overview of Key Companies in China In Vitro Diagnostics Market